Will you be attending DIA RSIDM next month? We’re looking forward to being (safely) back in person to discuss the challenges and opportunities within regulatory information and document management.
Visit us at Booth #202 to discuss recently updated strategies and solutions, the advantages of CSA validation, and to learn more about the meetup on the EDM Structured Submission Reference Model organized by fme’s own David Gwyn. You may have seen him presenting recently on building a more effective and efficient data-centric approach to document management in RIM.
If you haven’t reviewed and selected your sessions yet, here are just a few we feel are well-worth the time to attend. Hope to see you there!
Driving Performance from RIM
Enhance your processes to drive ultimate performance from your RIM technology. While describing the road to high performance, the speakers in this session will provide clear examples of regulatory metrics that will demonstrate a high performing RIM technology and how to make the most of country affiliates.
Is It Time to Streamline Your Processes with Structured Content Management?
The current standard processes for document management are no longer sufficient for streamlining submissions or able to support the level of content management, collaboration, and re-use that is possible with the transition from documents to data. This session focuses on practicalities and benefits of structured content management (SCM), including the benefits of transitioning from documents to data-centric processes, and practical use cases and key success factors for SCM.
IDMP Ontology: Semantic Interoperability Throughout the Entire Medicinal Product Lifecycle
This session outlines the implementation challenges of ISO IDMP standards at pharma companies and showcases how an ontology can help achieve semantic interoperability of product data.
How Innovative Collaboration Supports Compliance Across the Regulatory Ecosystem
This session will explore ways sponsors can achieve both greater control and compliance as well as improving their way of working together with health authorities to expand access to medicines.
Visit us at Booth #202
We are excited to participate in these valuable conversations with regulatory thought leaders, and re-connect with industry colleagues! Contact us to schedule a time to talk, or stop by Booth #202 to talk with our solution experts, and share your perspective and questions with the fme team. We look forward to speaking with you!